Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 0.50 0.40 0.55 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 3.2 -1.5 - 3

Motif Bio Share Discussion Threads

Showing 8751 to 8774 of 9100 messages
Chat Pages: Latest  352  351  350  349  348  347  346  345  344  343  342  341  Older
DateSubjectAuthorDiscuss
19/12/2020
15:49
You would like to think John Palmer of Tamarack would have run the document through spell check if it’s so important as it is to investors who were failed here by management. They can’t even spell Iclaprim correctly once which is massively disappointing
scottdavid70
19/12/2020
15:22
For example this from the Interims about the 30 companies they have diligently reviewed “ More than 30 opportunities have been carefully reviewed by the Board and discussions have progressed to the term sheet stage with several companies. The search is continuing for an appropriate RTO candidate with the goal of completing a transaction before 28 January 2021” Do they mean they ‘have’ which was current on the 12th October and still negotiating or ‘have’ but are no longer? The curtains of opaqueness is a set of principles Motif Bio, Walbrook PR and Peel Hunt have lived behind since 2015
scottdavid70
19/12/2020
13:37
The more you dig the more you find
scottdavid70
19/12/2020
12:33
When you look at John Palmers Tamarack Associates on LinkedIn and the 2 page document outlining the reasons to buy Iclaprim you have to ask yourself why it doesn’t mention the tie up with Lamellar and the cystic fibrosis that Graham took a grant for as well as it’s evaluation of Listeria using Iclaprim. Reading through it you can help but feel it’s a half hearted effort personally
scottdavid70
19/12/2020
11:14
Merely observed this STUNNING revelation that the Board decided to give themselves another Christmas present in 2019 along with the OUTRAGEOUS US$1.1 million that was paid to two directors whom were under “strict cost controls” by not reviewing their pitiful performance for shareholders. You can tell this omission of a review is a erroneous development that should never of been allowed to happen by their tone in the Annual Report
scottdavid70
19/12/2020
11:10
I'm stunned that you think "stunned" means "merely observed". Ok that's a lie, I'm just mildly amused.
bi11y ray va1entine
19/12/2020
10:59
Even the auditors are STUNNED in the Annual Report as they talk about the LACK OF A BOARD REVIEW INDIVIDUALLY OR COLLECTIVELY when they say “it’s is intended that this will be addressed following completion of a RTO or other qualifying transaction which may result in changes to the Board” Intended to address? What’s the point their whole ridiculous salary was based on getting Iclaprim approved but then told us they were implementing’strict cost controls” but took home 2 Of them almost US $1.1 MILLION I could do that review in 2 minutes. You are completely out of your depth, have failed your shareholders and should pack your things now. To not be reviewed is a scandal amongst the many here
scottdavid70
19/12/2020
10:36
But the bigger point is here without the review how do you know the Board members who have put the company in the abyss have the right skill set business wise to get you out of the abyss? How many of the current Board members on December 31st 3019 for example had been involved with a AIM Cash Shell and had done a Reverse Takeover for instance? I’ll wait...
scottdavid70
19/12/2020
10:34
How do you know without a comprehensive review of the Board members performance individually and collectively what went wrong, who said what and what could have been done differently?
scottdavid70
19/12/2020
10:33
How many people here have run companies where after a terrible, horrendous year you decide to not to do a review of the individuals who caused that particular disaster?
scottdavid70
19/12/2020
08:51
No wonder they decided as a group not or hold Board reviews individually or collectively after that sum of investors cash was shovelled into their respective accounts
scottdavid70
19/12/2020
08:34
Have to say it's not looking good at all.
lithological heterogeneities
19/12/2020
08:24
Answers on an email to Motif Bio and Walbrook PR Who thinks Graham Lumsden and Jon Golds take home pay collectively in 2019 of almost US $1.1 MILLION DOLLARS constitutes’strict cost controls’ that they kept telling investors was in place?
scottdavid70
19/12/2020
05:34
Usually I would agree but have used a fair bit of my contacts in various areas of the media and have several ways of making some income from this story once the final chapter is written of the book. Thanks for the advice. Am hoping all of you holding shares here get a good result ultimately
scottdavid70
18/12/2020
20:32
SD70- just a word of advice. Be careful what you do. Group intervention is better!
smcl
18/12/2020
20:17
SD70- just a word of advice. Be careful what you do. Group intervention is better!
smcl
18/12/2020
18:04
The more questions individually asked shows a complete lack of care for investors and I think that is a powerful trend to prove how they have treated ALL shareholders not just a few of us who have asked meaningful questions
scottdavid70
18/12/2020
17:29
Hi SD70- why don’t you put together a concise focused submission- short and to the point and get a number of shareholders here and on LSE to sign up and we could sent to the Company and it’s advisors. No point trying to do this on your own. No man is an island and all that. As a group we would be stronger. Have a think? Regards sm
smcl
18/12/2020
17:10
Was it all a big con Graham Lumsden? Is the alternating title in my head
scottdavid70
18/12/2020
16:55
One more week to announce a deal and then the 28th January 2021 is just the finish line for the delist. No more of Lumsdens promises of news that isn’t either correct or never materialises 5 business days until the final chapter of “The Dark Art of Being a AIM CEO” is written
scottdavid70
18/12/2020
14:00
Another week of leaving investors totally in the dark and the PR that is spent on outside companies is just money into thin air - this case study of incompetence and opaqueness vest murkier and better for my book everyday
scottdavid70
18/12/2020
10:03
Is that good Corporate Governance given how many other financial institutions we could have used to go back to them same one that knows Motifs skeletons?????
scottdavid70
18/12/2020
10:03
Closing in on 8 months since Scavenger Hunt picked the last remaining meat of the Motif carcass. Several RTO option then on the 1st June - 30 by 12th October - it’s like the Covid RTO pandemic - next we will be told it’s a 1000...
scottdavid70
18/12/2020
09:18
Bit of communication and honesty for the people who have paid your salary isn’t much to ask is it?
scottdavid70
Chat Pages: Latest  352  351  350  349  348  347  346  345  344  343  342  341  Older
ADVFN Advertorial
Your Recent History
LSE
MTFB
Motif Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210225 10:55:46